Relief Pathways: IV Ketamine vs Esketamine
While the usage of ketamine in clinical medicine has been in existence for fifty years, its breakthrough application for treatment-resistant depression is novel. So, what is new? Head-to-head formulation research studies comparing intravenous racemic ketamine versus intranasal esketamine (Spravato) are now emerging. We are excited to break down three findings from the first systematic review […]
